1. Home
  2. FXNC vs EDIT Comparison

FXNC vs EDIT Comparison

Compare FXNC & EDIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First National Corporation

FXNC

First National Corporation

HOLD

Current Price

$26.63

Market Cap

250.1M

Sector

Finance

ML Signal

HOLD

Logo Editas Medicine Inc.

EDIT

Editas Medicine Inc.

HOLD

Current Price

$2.11

Market Cap

206.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FXNC
EDIT
Founded
1907
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
250.1M
206.0M
IPO Year
2012
2016

Fundamental Metrics

Financial Performance
Metric
FXNC
EDIT
Price
$26.63
$2.11
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$4.50
AVG Volume (30 Days)
62.5K
1.3M
Earning Date
04-30-2026
01-01-0001
Dividend Yield
2.55%
N/A
EPS Growth
N/A
N/A
EPS
1.35
N/A
Revenue
$7,717,000.00
$31,937,000.00
Revenue This Year
$7.52
N/A
Revenue Next Year
$4.47
N/A
P/E Ratio
$19.80
N/A
Revenue Growth
7.40
132.64
52 Week Low
$18.26
$0.91
52 Week High
$28.89
$4.54

Technical Indicators

Market Signals
Indicator
FXNC
EDIT
Relative Strength Index (RSI) 46.08 56.03
Support Level $25.35 $1.94
Resistance Level $28.89 $2.76
Average True Range (ATR) 0.80 0.12
MACD -0.20 0.03
Stochastic Oscillator 2.18 97.53

Price Performance

Historical Comparison
FXNC
EDIT

About FXNC First National Corporation

First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. The Company operates through two reportable operating segments: Community Banking and wealth management. The Community Banking segment involves making loans and generating deposits from individuals, businesses, and charitable organizations. Wealth Management Services offers corporate trustee services, trust and estate administration, IRA administration and custody services. Key revenue is generated from Community Banking.

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.

Share on Social Networks: